We examined the value of the fasting plasma phenylalanine/tyrosine ratio obtained in an ordinary clinical setting for assessing the probability of being a heterozygote for hyperphenylalaninaemia. This biochemical test was found to be of little value in those with a high (66%) prior risk of heterozygosity, because it could not reduce the risk below 12%. However, in a population with a prior risk of only 2%, it discriminates the 3% with a 19% risk from the 97% with a risk of 1.5% or less. This simple method could usefully be applied to such a population, in order to select those at higher risk for further investigation using molecular genetics.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Anderson JA, Graven H, Ertel R, Fisch R (1962) Identification of heterozygotes with phenylketonuria on basis of blood tyrosine responses.J Pediatr 61: 603–609.
Berry H, Sutherland B, Guest GM (1957) Phenylalanine tolerance tests on relatives of phenylketonuric children.Am J Hum Genet 9: 310–316.
Blau K, Summer GK, Newsome HC, Edwards CH, Mamer OA (1973) Phenylalanine loading and aromatic acid secretion in normal subjects and heterozygotes for phenylketonuria.Clin Chim Acta 45: 183–192.
Brown ES, Waisman HA, Swanson MA, Colwell RE, Banks ME, Gerritsen T (1973) Effects of oral contraceptives and obesity on carrier tests for phenylketonuria.Clin Chim Acta 44: 183–192.
Bundey S (1978) Calculation of genetic risks in Duchenne muscular dystrophy by geneticists in the United Kingdom.J Med Genet 15: 249–253.
Davey JF, Ersser RS (1990) Amino acid analysis of physiological fluids by high-performance liquid chromatography with phenylisothiocyanate derivatization and comparison with ion-exchange chromatography.J Chromatogr 528: 9–23.
Dennis NR, Carter CO (1978) Use of overlapping normal distributions in genetic counselling.J Med Genet 15: 106–108.
Griffin RF, Humienny ME, Hall EC, Elsas LJ (1973) Classic phenylketonuria: heterozygote detection during pregnancy.Am J Hum Genet 25: 646–654.
Guttler F, Hansen G (1977) Heterozygote detection in phenylketonuria.Clin Genet 11: 137–146.
Hsia DY, Driscoll KW, Troll W, Knox WE (1956) Detection by phenylalanine tolerance tests of heterozygous carriers of phenylketonuria.Nature 178: 1239–1240.
Jackson SH, Hanley WB, Gero T, Gosse GD (1971) Detection of phenylketonuria heterozygotes.Clin Chem 17: 538–543.
Konecki DS, Lichter-Konecki U (1991) The phenylketonuria locus: current knowledge about alleles and mutations of the phenylalanine hydroxylase gene in various populations.Hum Genet 87: 377–388.
Perry TL, Tischler B, Hansen S, MacDougal L (1967a) A simple test for heterozygosity for phenylketonuria.Clin Chim Acta 15: 47–55.
Perry TL, Hansen S, Tischler B, Bunting R (1967b) Determination of heterozygosity for phenylketonuria on the amino acid analyzer.Clin Chim Acta 18: 51–56.
Rampini S, Anders PW, Curtius HC, Marthaler T (1969) Detection of heterozygotes for phenylketonuria by column chromatography and discriminatory analysis.Pediatr Res 3: 287–297.
Renwick JH, Lawler SD, Cowie VA (1960) Phenylketonuria: a linkage study using phenylalanine tolerance tests.Am J Hum Genet 12: 287–322.
Rosenblatt D, Scriver CR (1968) Heterogeneity in genetic control of phenylalanine metabolism in man.Nature 218: 677–678.
Scriver CR, Kaufman S, Woo SLC (1989) The hyperphenylalaninaemias. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds.The Metabolic Basis of Inherited Disease, 6th Edn. New York: McGraw-Hill, 495–546.
Smith I, Cook B, Beasley M (1991) Review of neonatal screening programme for phenylketonuria.Br Med J 303: 333–335.
Wang HL, Morton NE, Waisman HA (1961) Increased reliability for the determination of the carrier state in phenylketonuria.Am J Hum Genet 13: 255–261.
Westwood A, Raine DN (1975) Heterozygote detection in phenylketonuria — measurement of discriminatory ability and interpretation of the phenylalanine loading test by determination of the heterozygote likelihood ratio.J Med Genet 12: 327–333.
About this article
Cite this article
Saraiva, J.M., Seakins, J.W.T. & Smith, I. Plasma phenylalanine and tyrosine levels revisited in heterozygotes for hyperphenylalaninaemia. J Inherit Metab Dis 16, 105–109 (1993). https://doi.org/10.1007/BF00711323
- Public Health
- High Risk
- Internal Medicine
- Clinical Setting